United Therapeutics
UTHR
#1121
Rank
S$28.17 B
Marketcap
S$656.96
Share price
-2.36%
Change (1 day)
26.45%
Change (1 year)

EPS for United Therapeutics (UTHR)

EPS in 2026 (TTM): S$37.61

According to United Therapeutics's latest financial reports the company's current EPS (TTM) is S$37.37. In 2025 the company made an earnings per share (EPS) of S$38.47 an increase over its 2024 EPS that were of S$33.71.

EPS history for United Therapeutics from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$37.61-2.24%
2025S$38.4714.1%
2024S$33.7125.59%
2023S$26.8431.54%
2022S$20.4151.18%
2021S$13.50-9.1%
2020S$14.85-581.4%
2019S-$3.08-117.79%
2018S$17.3342.11%
2017S$12.20-40.93%
2016S$20.6513.45%
2015S$18.20104.29%
2014S$8.91100.29%
2013S$4.45

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
S$1.67-95.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$35.97-3.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$2.71-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
S$9.46-74.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
S$8.37-77.59%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$4.95-86.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Cytokinetics
CYTK
S-$8.72-123.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$1.75-95.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel